The US drug regulator has approved the Armlupeg (pegfilgrastim-unne) 6mg / 0.6 ml injection for subcutaneous use in a ...
Mumbai, Aug. 26 -- The company also received tentative approval for the (0.2 Units/mL) RTU vials of the same formulation. The product is bioequivalent and therapeutically equivalent to the reference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback